Advertisement

Breast Cancer Research and Treatment

, Volume 45, Issue 2, pp 169–179 | Cite as

Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth

  • James A. Bennett
  • Daniel J. Semeniuk
  • Herbert I. Jacobson
  • Robert A. Murgita
Article

Abstract

Alpha-fetoprotein (AFP) isolated from rodent amniotic fluid orhuman cord sera, upon incubation with a molarexcess of estradiol, is converted to a formwhich inhibits estrogen-stimulated tissue growth. The purpose ofthis study was to determine whether recombinant humanAFP produced in an E. coli expression systemretained this function. The recombinant protein was similarto the natural protein isolated from pooled humancord sera in all functional aspects evaluated. Itwas detected by monoclonal and polyclonal antibodies tothe natural protein. Following exposure to estradiol, itwas converted to an inhibitor of estrogen-stimulated growthof immature mouse uterus yielding a dose/response curvesimilar to that of the natural protein. Itinhibited the growth of estrogen-dependent (MCF-7) but notestrogen-independent (MDA-MB-231) breast cancer xenografts with the sameschedule dependency and resultant histological changes as thenatural protein. Availability of large quantities of homogeneous,biologically active recombinant human AFP will facilitate furtherstudies of structure/function, mechanism, and therapeutic potential ofthis agent as a regulator of breast cancergrowth.

alpha-fetoprotein breast cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Crandall BF: Alpha-fetoprotein: a review. CRC Crit Rev Clin Lab Sci 15: 127–185, 1981Google Scholar
  2. 2.
    Ruoslahti E, Terry WD: Alpha-fetoprotein and serum albumin show sequence homology. Nature 260: 804–806, 1976Google Scholar
  3. 3.
    Abelev GS: Alpha-fetoprotein in autogenesis and its association with malignant tumors. Adv Cancer Res 14: 295–340, 1971Google Scholar
  4. 4.
    Van Oers NSC, Cohen BL, Murgita RA: Isolation and characterization of a distinct immunoregulatory isoform of α-fetoprotein produced by the normal fetus. J Exp Med 170: 811–825, 1989Google Scholar
  5. 5.
    Toder V, Blank M, Gold-Gefter L, Nebel L: The effect of alpha-fetoprotein on the growth of placental cells in vitro. Placenta 4: 79–86, 1983Google Scholar
  6. 6.
    Keel BA, Eddy KB, Cho S, Gangrade BK, May JV: Purified human alpha-fetoprotein inhibits growth factor-stimulated estradiol production by porcine granulosa cells in monolayer culture. Endocrinology 130: 3715–3717, 1992Google Scholar
  7. 7.
    Mizejewski GJ, Vonnegut M, Jacobson HI: Estradiol-activated α-fetoprotein suppresses the uterotrophic response to estrogens. Proc Natl Acad Sci USA 80: 2733–2737, 1983Google Scholar
  8. 8.
    Deutsch HF: Chemistry and biology of alpha-fetoprotein. Adv Cancer Res 56: 253–312, 1991Google Scholar
  9. 9.
    Soloff MS, Creange JE, Potts GO: Unique estrogen-binding properties of rat pregnancy plasma. Endocrinology 88: 427–432, 1971Google Scholar
  10. 10.
    Swartz SK, Soloff MS: The lack of estrogen binding by human α-fetoprotein. J Clin Endocrinol Metab 39: 589–591, 1974Google Scholar
  11. 11.
    Jacobson HI, Marotta D, Mizejewski GJ, Bennett JA, Andersen TT: Estradiol-induced changes in spectral and biological properties of alpha-fetoprotein. Tumour Biol 11: 104, 1990Google Scholar
  12. 12.
    Jacobson HI, Bennett JA, Mizejewski GJ: Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol. Cancer Res 50: 415–420, 1990Google Scholar
  13. 13.
    Allen SHG, Bennett JA, Mizejewski GJ, Andersen TT, Ferraris S, Jacobson HI: Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity. Biochim Biophys Acta 1202: 135–142, 1993Google Scholar
  14. 14.
    Bennett JA, Allen SHG, Andersen TT, Gierthy JF, Mizejewski GJ, Jacobson HJ: Inhibition of human MCF-7 breast cancer growth by estradiol (E2)-activated human alpha-fetoprotein (AFP). J Cancer Res Clin Oncol 116(Suppl 1): 460, 1990Google Scholar
  15. 15.
    Bennett JA, Semeniuk D, Jacobson HI, Murgita RA: Recombinant human alpha-fetoprotein is similar to the natural protein in its transformability to an inhibitor of estrogen-dependent breast cancer growth. Proc Am Assoc Cancer Res 36: 262, 1995Google Scholar
  16. 16.
    Boismenu R, Semeniuk DJ, Murgita RA: Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli. Protein Expression Purification, 10–26, 1997Google Scholar
  17. 17.
    Tanaka Y, Wu AS, Kiekawa N, Iseki K, Kawai M, Kobayashi Y: Inhibition of HT-29 human colon cancer growth under the renal capsule of severe combined immunodeficient mice by an analogue of 1,25-dihydroxyvitamin D3, DD-003. Cancer Res 54: 5148–5153, 1994Google Scholar
  18. 18.
    Osborne CK, Hobbs K, Clark GM: Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584–590, 1985Google Scholar
  19. 19.
    Altman DJ, Schneider SL, Thompson DA, Cheng HL, Tomasi TB: A transforming growth factor β2 (TGF-β2)-like immunosuppressive factor in amniotic fluid and localization of TGF-β2 mRNA in the pregnant uterus. J Exp Med 172: 1391–1401, 1990Google Scholar
  20. 20.
    Semeniuk DJ, Boismenu R, Tam J, Weissenhober W, Murgita RA: Evidence that immunosuppression is an intrinsic property of the alpha-fetoprotein molecule. In: Atassi MZ, Bixler GS Jr (eds) Immunobiology of Proteins and Peptides. Plenum, New York, 1995, pp 255–269Google Scholar
  21. 21.
    Vallette G, Benassayag C, Belanger L, Nuñez EA, Jayle MF: Rat iso-alpha-fetoproteins: purification and interaction with estradiol-17β. Steroids 29: 277–289, 1977Google Scholar
  22. 22.
    Morinaga T, Sakai M, Wegmann TG, Tamaoki T: Primary structures of human α-fetoprotein and its mRNA. Proc Natl Acad Sci USA 80: 4604–4608, 1983Google Scholar
  23. 23.
    Bennett JA, Mizejewski GJ, Allen SHG, Zhu SJ, Jacobson HI: Transformability of alpha-fetoprotein to a negative regulator of estrogen-dependent growth by ligands of the steroid/thyroid hormone receptor superfamily. Proc Am Assoc Cancer Res 34: 244, 1993Google Scholar
  24. 24.
    Villacampa MJ, Moro R, Naval J, Failly-Crepin C, Lampreave F, Uriel J: Alpha-fetoprotein receptors in a human breast cancer line. Biochem Biophys Res Commun 122: 1322–1327, 1984Google Scholar
  25. 25.
    Wu T, Waterhouse WJ: Identification of alpha-fetoprotein polymers. Artifacts of the isolation procedure. Clinica Chimica Acta 125: 9–19, 1982Google Scholar
  26. 26.
    Sarcione EJ, Zloty M, Delluomo DS, Mizejewski GJ, Jacobson HI: Detection and measurement of α-fetoprotein in human breast cancer cytosol after treatment with 0.4 M potassium chloride. Cancer Res 43: 3739–3741, 1983Google Scholar
  27. 27.
    Mizejewski GJ: An apparent dimerization motif in the third domain of alpha-fetoprotein: Molecular mimicry of the steroid/thyroid nuclear receptor superfamily. Bioessays 15: 427–432, 1993Google Scholar
  28. 28.
    Wang W, Alpert E: Downregulation of phorbol 12-myristate 13-acetate-induced tumor necrosis factor-alpha and interleukin-1β production and gene expression in human monocytic cells by human alpha-fetoprotein. Hepatology 22: 921–928, 1995Google Scholar
  29. 29.
    Aussel C, Lafaurie M, Masseyeff R, Stora C: In vivo regulation of ovarian activity by alpha-fetoprotein. Steroids 38: 195–204, 1981Google Scholar
  30. 30.
    Buschman E, Van Oers N, Katz M, Murgita RA: Experimental myasthenia gravis induced in mice by passive transfer of human myasthenic immunoglobulin. Evidence for an ameliorating effect by alpha-fetoprotein. J Neuroimmunol 13: 315–330, 1987Google Scholar
  31. 31.
    Ogata A, Yamashita T, Koyama Y, Sakai M, Nishi S: Suppression of experimental antigen-induced arthritis in transgenic mice producing human α-fetoprotein. Biochem Biophys Res Commun 213: 362–366, 1995Google Scholar

Copyright information

© Kluwer Academic Publishers 1997

Authors and Affiliations

  • James A. Bennett
    • 1
  • Daniel J. Semeniuk
    • 2
  • Herbert I. Jacobson
    • 1
  • Robert A. Murgita
    • 2
  1. 1.Albany Medical CollegeAlbanyUSA
  2. 2.McGill UniversityMontrealCanada

Personalised recommendations